Arbutus Biopharma (ABUS) Goodwill & Intangibles (2015 - 2019)

Arbutus Biopharma has disclosed Goodwill & Intangibles across 5 years of filings, most recently posting $66.3 million for Q2 2019.

• Goodwill & Intangibles for Q2 2019 came in at $66.3 million, down 18.26% year-over-year; the trailing twelve-month figure through Jun 2019 was $66.3 million (down 18.26% YoY), and the FY2018 annual result was $66.3 million, down 20.12% from the prior year.
• Goodwill & Intangibles came in at $66.3 million for Q2 2019 at Arbutus Biopharma, roughly flat from $66.3 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $546.1 million in Q2 2015 to a low of $66.3 million in Q3 2018.
• The 5-year median for Goodwill & Intangibles is $123.8 million (2016), against an average of $242.1 million.
• Peak annual rise in Goodwill & Intangibles reached 5.57% in 2016, while the deepest fall reached 75.97% in 2016.
• Arbutus Biopharma's Goodwill & Intangibles stood at $515.2 million in 2015, then slumped by 75.97% to $123.8 million in 2016, then sank by 32.95% to $83.0 million in 2017, then decreased by 20.12% to $66.3 million in 2018, then changed by 0.0% to $66.3 million in 2019.
• The last three Goodwill & Intangibles figures came in at $66.3 million (Q2 2019), $66.3 million (Q1 2019), and $66.3 million (Q4 2018), per Business Quant data.